Atomoxetine resulting in Takotsubo syndrome: is the locally-released norepinephrine from the autonomic sympathetic cardiac nerves or the blood-borne catecholamines the cause?
Icahn School of Medicine at Mount Sinai, New York, NY, USA, madiasj@nychhc.org.
John E
JE
Madias
D018759:Adrenergic Uptake Inhibitors / Q000009:adverse effects*; D000069445:Atomoxetine Hydrochloride; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy*; D002648:Child; D006321:Heart / Q000294:innervation*; D006801:Humans; D008297:Male; D009638:Norepinephrine / Q000378:metabolism*; D011437:Propylamines / Q000009:adverse effects*; D013564:Sympathetic Nervous System / Q000503:physiopathology*; D054549:Takotsubo Cardiomyopathy / Q000139:chemically induced* / Q000503:physiopathology
D018759:Adrenergic Uptake Inhibitors; D011437:Propylamines; D000069445:Atomoxetine Hydrochloride; D009638:Norepinephrine